Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Hold
0
-$313K 1091
2024
Q4
Hold
0
1091
2024
Q3
Hold
0
985
2024
Q2
Hold
0
902
2024
Q1
Hold
0
802
2023
Q4
Hold
0
622
2023
Q3
Hold
0
596
2023
Q2
Hold
0
639
2023
Q1
Hold
0
563
2022
Q4
Hold
0
415
2022
Q3
Hold
0
414
2022
Q2
Sell
-1,400
Closed -$343K 409
2022
Q1
$339K Buy
+1,400
New +$322K 0.01% 429

Other funds holding AMGN

Savant Capital's AMGN Position: Q1 2026 in Review

Savant Capital increased its Amgen (AMGN) stake by 5.9% in Q1 2026, buying an estimated $505K and bringing the position to 25,466 shares worth $8.96M. The position accounts for 0.04% of the portfolio, ranked #196.

Savant Capital first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.46M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Savant Capital held 25,466 shares of Amgen worth $8.96M as of Q1 2026.
  • Savant Capital bought 1,417 Amgen shares in Q1 2026, an estimated $505K.
  • Amgen made up 0.04% of Savant Capital's portfolio in Q1 2026, its #196 holding.
  • Savant Capital first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Savant Capital's Amgen position peaked at $9.46M in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.